Eulav Asset Management Idexx Laboratories Inc Transaction History

Eulav Asset Management

$4.25 Billion
Q2 2025

A detailed history of Eulav Asset Management transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Eulav Asset Management holds 126,217 shares of IDXX stock, worth $80.4 Million. This represents 1.59% of its overall portfolio holdings.

Number of Shares

126,217

Previous 126,215 -0.0%

Holding current value

$80.4 Million

Previous $53 Million 27.72%

% of portfolio

1.59%

Previous 1.3%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$361.04 - $536.34 $722 - $1,072	2 Added 0.0%	126,217 $67.7 Million
Q1 2025 Apr 29, 2025	BUY	$406.29 - $469.04 $1,218 - $1,407	3 Added 0.0%	126,215 $53 Million
Q2 2024 Aug 13, 2024	BUY	$468.04 - $548.53 $2.9 Million - $3.4 Million	6,197 Added 5.16%	126,212 $61.5 Million
Q1 2024 May 30, 2024	BUY	$515.08 - $576.87 $7.16 Million - $8.02 Million	13,903 Added 13.1%	120,015 $64.8 Million
Q3 2023 Nov 13, 2023	SELL	$432.42 - $556.67 $1.9 Million - $2.45 Million	-4,400 Reduced 3.98%	106,112 $46.4 Million
Q2 2023 Aug 09, 2023	SELL	$450.7 - $503.61 $3.87 Million - $4.33 Million	-8,588 Reduced 7.21%	110,512 $55.5 Million
Q1 2023 Apr 27, 2023	BUY	$406.01 - $514.59 $10.2 Million - $12.9 Million	25,000 Added 26.57%	119,100 $59.6 Million
Q4 2022 Feb 14, 2023	BUY	$324.64 - $441.27 $10.7 Million - $14.5 Million	32,900 Added 53.76%	94,100 $38.4 Million
Q2 2022 Jul 22, 2022	SELL	$327.37 - $553.44 $6.48 Million - $11 Million	-19,800 Reduced 24.44%	61,200 $21.5 Million
Q1 2022 May 10, 2022	SELL	$466.52 - $631.01 $1,866 - $2,524	-4 Reduced -0.0%	81,000 $44.3 Million
Q4 2021 Feb 11, 2022	SELL	$586.54 - $666.48 $7.74 Million - $8.8 Million	-13,200 Reduced 14.01%	81,004 $53.3 Million
Q1 2021 Apr 30, 2021	SELL	$465.18 - $551.79 $2.32 Million - $2.76 Million	-4,998 Reduced 5.04%	94,204 $46.1 Million
Q4 2020 Feb 16, 2021	SELL	$383.85 - $499.87 $3.84 Million - $5 Million	-9,998 Reduced 9.16%	99,202 $49.6 Million
Q2 2020 Aug 11, 2020	SELL	$230.66 - $330.16 $11.3 Million - $16.1 Million	-48,900 Reduced 30.93%	109,200 $36.1 Million
Q4 2019 Feb 13, 2020	SELL	$248.66 - $285.01 $4 Million - $4.59 Million	-16,100 Reduced 9.24%	158,100 $41.3 Million
Q3 2019 Nov 12, 2019	SELL	$260.07 - $289.93 $598,161 - $666,839	-2,300 Reduced 1.3%	174,200 $47.4 Million
Q2 2019 Aug 05, 2019	SELL	$215.53 - $275.33 $258,636 - $330,396	-1,200 Reduced 0.68%	176,500 $48.6 Million
Q3 2018 Oct 26, 2018	SELL	$218.82 - $254.46 $1.16 Million - $1.35 Million	-5,300 Reduced 2.9%	177,700 $44.4 Million
Q2 2018 Aug 14, 2018	SELL	$185.56 - $227.9 $3.77 Million - $4.63 Million	-20,300 Reduced 9.99%	183,000 $39.9 Million
Q1 2018 May 09, 2018	SELL	$157.81 - $204.73 $4.29 Million - $5.57 Million	-27,200 Reduced 11.8%	203,300 $38.9 Million
Q4 2017 Feb 14, 2018	SELL	$147.68 - $168.37 $1.02 Million - $1.16 Million	-6,900 Reduced 2.91%	230,500 $36 Million
Q2 2017 Aug 14, 2017	BUY	N/A	237,400	237,400 $38.3 Million

Others Institutions Holding IDXX

# of Institutions

1,384

Shares Held

75.2M

Call Options Held

177K

Put Options Held

226K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $53.1B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eulav Asset Management with notifications on news.

Account

Eulav Asset Management Idexx Laboratories Inc Transaction History